{"nct_id":"NCT02477800","title":"221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease","status":"TERMINATED","status_verified_date":"2021-08","start_date":"2015-08-13","start_date_type":"ACTUAL","primary_completion_date":"2019-08-08","primary_completion_date_type":"ACTUAL","completion_date":"2019-08-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["BIIB"]}